GNFT: Utang jangka cendhak perusahaan Genfit SA

Current price action for Genfit S.A. (GNFT) reflects a current short-term debt metric of 0.00. The business focuses on developing therapies for liver pathologies. Patents for diagnostics and centers in France and the US ensure stability. Growth is driven by licensing agreements and joint R&D projects with global behemoths without pursuing merger deals.

Genfit S.A. focuses on laboratory development of liver therapy drugs while adhering to strict FDA safety protocols. The trend in total short-term debt reflects the issuer's obligations with maturities of up to one year. This metric captures current liquidity, excluding temporary gaps between quarterly reports. A reduction in the debt load minimizes financial risks, although a sharp decline may indicate a reduction in the credit limit. This determines the overall capital stability of the company.